The posteromedial cortices and other regions of the ''default network'' are particularly vulnerable to the pathology of Alzheimer disease (AD). In this study, we performed functional magnetic resonance imaging (fMRI) to investigate whether the presence of apolipoprotein E (APOE) e4 allele and degree of memory impairment were associated with the dysfunction of these brain regions. Seventy-five elderly subjects ranging from cognitively normal to mild AD, divided into e4 carriers and noncarriers, underwent fMRI during a memory-encoding task. Across all subjects, posteromedial and ventral anterior cingulate cortices (key components of the default network) as well as right middle and inferior prefrontal regions demonstrated reduced task-induced deactivation in the e4 carriers relative to noncarriers. Even among cognitively normal subjects, e4 carriers demonstrated reduced posteromedial deactivation compared with the noncarriers in the same regions which demonstrated failure of deactivation in AD patients. Greater failure of posteromedial deactivation was related to worse memory performance (delayed recall) across all subjects and within the range of cognitively normal subjects. In summary, the posteromedial cortical fMRI response pattern is modulated both by the presence of APOE e4 and episodic memory capability. Altered fMRI activity of the posteromedial areas of the brain default network may be an early indicator of risk for AD.
T he structure and function of the posteromedial association cortices has garnered increasing attention as a potential indicator of prodromal Alzheimer disease (AD). functional magnetic resonance imaging (fMRI) studies in AD patients, compared with healthy elderly, have demonstrated alterations in posteromedial cortical activity during goal-directed task performance versus low-level baseline conditions-termed as impaired task-induced deactivation or default network activity. [1] [2] [3] [4] Functional connectivity between the posteromedial cortices and other brain regions such as the medial temporal lobe is reported to be impaired even in subjects with mild cognitive impairment (MCI). 5, 6 Some structural MRI studies, but not all, have reported gray matter atrophy within the posteromedial cortices in MCI, particularly in subjects who progressed to clinical AD compared with those who remained cognitively stable. 7, 8 Optimally, however, prodromal AD would be detected before prominent structural atrophy-for example using functional imaging methods-at a point when diseasemodifying therapies still might be able to prevent the progression to clinical dementia.
The primary known genetic risk factor for sporadic AD is the e4 allele of the apolipoprotein E (APOE) gene. 9, 10 Previous [
18 F]fluorodeoxyglucose positron emission tomography (PET) studies in cognitively normal e4 carriers, compared with noncarriers, have reported hypometabolism in the posteromedial cortices, 11, 12 in brain areas similar to those demonstrating impaired fMRI task-induced deactivation [1] [2] [3] [4] and reduced glucose metabolism [13] [14] [15] [16] in AD patients relative to healthy elderly controls. The effect of e4 on the relative task-induced increases and decreases in fMRI signal remains, however, to be investigated. As the earliest and most salient cognitive deficit in AD is the inability to form enduring episodic memories, investigation of alterations in fMRI activity during memory encoding is of particular interest in subjects at genetic risk for AD.
In this study, we investigated older individuals across a range from cognitively intact to mild AD, with fMRI during associative encoding of face-name pairs. Our goal was to determine whether dysfunction of the same brain regions, which differentiate AD patients from healthy elderly, would relate to the presence of APOE e4 allele and demonstrate a significant relationship with episodic memory performance. We hypothesized that fMRI activity of the posteromedial cortical areas of the default network would be impaired even in healthy elderly individuals at genetic risk for AD, and that more impaired posteromedial activity would relate to increasing impairment of episodic memory. The subjects were classified on the basis of their Clinical Dementia Rating (CDR) scores 17 (Table 1) : healthy elderly with a CDR score of 0.0 (n = 30); cognitively mildly impaired subjects with CDR 0.5, not demented (n = 30); subjects with mild dementia severity in terms of CDR 1.0 who also met the National Institute of Neurological and Communicative Diseases and Stroke/Alzheimers Disease and Related Disorders Association criteria 18 for probable AD (n = 15). AD patients had either been off cholinesterase inhibitors for at least 30 days before scanning or had never taken these medications. Sixty-five of the participants (older controls: n = 30; MCI: n = 30; and AD: n = 5) were recruited from a longitudinal study examining preclinical predictors of AD, and underwent additional neuropsychologic testing. The remaining 10 subjects (AD: n = 10) were recruited from memory disorder clinics. A subset of these subjects have been previously reported in 1 study using anatomically defined regions of interest limited to the medial temporal lobe (n = 29) 19 and in another study using independent component analysis (n = 52). 20 For the purposes of this study (to investigate the relationship between episodic memory performance and regional fMRI activity), age-adjusted and education-adjusted Z-scores for the Rey Auditory Verbal Learning Test (RAVLT) delayed recall measures were calculated based on a large group of normal older subjects in our community. 21 
METHODS Subjects
Seventy
APOE Genotyping
The APOE polymorphisms were genotyped by restriction fragment length analysis following polymerase chain reaction from B10 ng of genomic DNA, as described previously. 22 Among the 75 subjects, there were 28 APOE e4 allele carriers (37%) ( Table 2) . When dividing the CDR groups into subgroups on the basis of the e4 status, there were 9 out of 30 CDR 0.0 e4 carriers (30%), 10 out of 30 CDR 0.5 e4 carriers (33%), and 9 out of 15 CDR 1.0 e4 carriers (60%). In this sample, there were 2 e4 homozygotes, 1 in the CDR 0.0 and 1 in the CDR 0.5 group.
fMRI Paradigm and Postscan Memory Test
The fMRI paradigm consisted of blocks of novel and repeated face-name pairs alternating with visual fixation. 23 For the fixation baseline, the participants were instructed to focus their attention on a white crosshair presented on the black background. For the novel and repeated activation conditions, they were instructed to try (1) to remember the name associated with each face, (2) to make a subjective decision regarding whether or not they thought the name that ''fit'' the face, and (3) to press the response button with their index or middle finger accordingly. Each of the 6 fMRI runs consisted of 3 different conditions: 2 novel blocks (7 face-name pairs per block, each shown for 5 s) and 2 repeated blocks (2 randomly alternating face-name pairs) of identical length, separated by 25 seconds periods of fixation. The duration of the novel and repeated blocks combined was 140 seconds, and the duration of the fixation was 115 seconds per each run. Visual stimuli were presented using MacStim 2.5 software (WhiteAnt Occasional Publishing, West Melbourne, Australia). Images were projected through a collimating lens onto a screen attached to the head coil. Responses were collected using a fiber-optic response box held in the right hand.
After the scanning session all subjects underwent a forced-choice associative recognition memory test. During this ''name recognition'' test, a set of 12 novel faces seen 28.9 ± 1.1 (27) (28) (29) (30) 23.2 ± 5.2 (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) 23.3 ± 3.7 (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) RAVLT delayed recall (range)z
GM volume GM volume Â during the experiment and the 2 repeated faces were presented on a computer screen. Each face was shown with 2 names printed underneath: the correct name that was paired with the face during scanning and 1 incorrect name that was previously paired with a different face during scanning. The subjects were instructed to indicate the correct name by pointing to it on the computer monitor.
MRI Data Acquisition
Subjects were scanned using a Siemens Trio 3.0 T scanner (Siemens Medical Systems, Iselin, NJ) equipped for echo-planar imaging. High-resolution structural images were acquired using a T 1 -weighted 3 dimensional magnetization prepared rapid acquisition gradient echo sequence with the following parameters: repetition time = 2530 ms, echo time = 3.45 ms, inversion time = 1100 ms, flip angle = 7 degree, field of view = 256 mm, matrix 192 Â 256, slice thickness = 1.33 mm, and 128 sagittal slices. Bloodoxygen-level-dependent (BOLD) fMRI data were scanned using a T 2 * -weighted gradient-echo echo-planar imaging sequence 
Demographic and Cognitive Data Analysis
Differences in age, education, and cognitive performance were tested using the nonparametric Mann-Whitney U test and differences in sex distribution using w 2 test in SPSS 14.0 (SPSS Inc, Chicago, IL). The level of statistical significance was set at P<0.05.
Structural MRI Data Analysis
Brain gray matter volume, normalized for head size, was estimated in a fully automated way with SIENAX, part of FSL. 24 Brain and skull images were first extracted from the single whole-head input data of each subject. Brain images were affine-registered to Montreal Neurological Institute (MNI) space (using the skull image to determine the registration scaling). Peripheral gray matter volumes were then calculated using tissue-type segmentation with partial volume estimation. Differences in gray matter volumes between groups were tested using the MannWhitney U test in SPSS 14.0 and considered statistically significant at P<0.05.
fMRI Data Analysis
The goal of this study was to investigate alterations in fMRI activity in the default network and related association cortical areas. To this aim, active processing of novel face-name pairs was contrasted to the fixation baseline. Both increase and decrease in BOLD signal evoked during task performance were examined. FMRI data analysis was carried out using FEAT 5.63, part of FSL (www.fmrib.ox.ac. uk/fsl). The following prestatistical processing was applied: motion correction, removal of nonbrain structures, spatial smoothing using a Gaussian kernel of full width at half maximum of 5 mm, mean-based intensity normalization of all volumes by the same factor, and high-pass temporal filtering with a frequency cut-off point of 140.0 seconds. Time-series statistical analysis was carried out using FILM with local autocorrelation correction. fMRI images were registered to high-resolution structural images and to the MNI standard brain using FLIRT and 12 parameter affine registration.
Higher-level between-group analyses were carried out using FLAME including age, sex, and gray matter volume as covariates. 25 FSL mixed-effects modeling exploits 2-sample unpaired t tests for between-group analyses. The resulting Z-statistic images (Gaussianised T statistic images) were corrected for multiple comparisons using cluster thresholding. 26 To perform cluster thresholding, default FSL values for the voxelwise Z-statistic threshold (Z>2.3) and the cluster probability threshold (P<0.05) were applied. Analyses between e4 carriers and noncarriers were confined to regions affected in AD by using the wholebrain statistical map (P<0.05, cluster-corrected) resulting from the comparison between healthy elderly (CDR = 0.0) and AD patients (CDR = 1.0) as a mask (Table 3 , Figs. 1, 2) .
The region-of-interest (ROI) analysis of BOLD signal magnitude was performed by positioning the center of a sphere 5 voxels in diameter into the peak MNI coordinates in the e4 carriers versus noncarriers statistical maps. Mean BOLD signal change (in percentages) during processing novel face-name pairs versus fixation was extracted for each subject and region using FSL featquery and entered into SPSS for statistical analysis using the 1-way analysis of variance, 2-sample unpaired t tests and Pearson correlation. The ROI analyses were performed to complement the FSL group-level data analyses by investigating the directionality of the BOLD signal differences and also to provide some insight into the inter-individual variability of the fMRI response across the elderly subject groups. Of the results presented below, the correlations with the memory measures as well as the bar graphs and scatter plots presented in Figures 1 and 2 are based on the ROI analyses of fMRI signal response. 
RESULTS

Subject Characteristics
The 3 clinical groups (healthy elderly with CDR 0.0, mildly impaired subjects with CDR 0.5, and AD patients with CDR 1.0) differed on several demographic and cognitive variables as indicated in Table 1 . In contrast, there were no differences in demographic or cognitive characteristics between e4 carriers and noncarriers either across all subjects or within each CDR group ( Table 2 ), except that the CDR 1.0 e4 carriers had lower (P = 0.002) and the CDR 0.5 e4 carriers higher (P = 0.02) CDR sum-of-boxes scores than the noncarriers.
Gray Matter Volumes
The mean gray matter volume was significantly smaller in AD patients than in the CDR 0.5 (P = 0.001, MannWhitney U test) and CDR 0.0 (P<0.0001) subjects (Table 1 ). There were no differences in gray matter volumes between all e4 carriers and noncarriers or between the APOE groups within the CDR groups ( Table 2) .
fMRI-Areas of Altered Activity in AD Compared With Healthy Elderly
We first compared AD patients (CDR 1.0) with the healthy elderly (CDR 0.0) during the processing of novel face-name pairs compared with fixation. Significant differences in fMRI activity (P<0.05, cluster-corrected) were found in: right and left precuneus and posterior cingulum, dorsal anterior cingulum, left supramarginal gyrus, and right ventral anterior cingulum; right middle frontal and right and left inferior frontal and insular cortices; right and left occipital pole, right lingual and left temporopolar cortices, left hippocampus, and the surrounding rhinal cortex (Table 3 , Fig. 1 ). The whole-brain statistical map resulting from the AD versus healthy elderly between-group comparison comprising brain regions listed above was used as a mask to confine further data analyses to the areas affected in AD. As can be seen in Figure 1 , among the brain regions affected both by AD and APOE e4 allele, all areas (Figs. 1A-D) except the dorsal anterior cingulate cortex (Fig. 1E ) demonstrated greater positive BOLD fMRI signal in AD patients than in healthy elderly subjects.
fMRI-Effect of APOE e4 and Correlations With Memory Performance Across All Subjects
We then compared fMRI activity between APOE e4 carriers and noncarriers across all 75 subjects within the brain areas affected in AD as described above. (Fig. 1) .
ROI analysis revealed that in each of these regions fMRI signal was more positive (less task-induced deactivation or more activation) in the e4 carriers than in noncarriers (Fig. 1) . In the precuneal and ventral anterior cingulate ROIs, we found the most negative BOLD signal (the greatest task-induced deactivation) in the healthy elderly e4 noncarriers and the most positive BOLD signal (paradoxical activation) in the AD e4 carriers.
In the 65 subjects with additional neuropsychologic testing, we further investigated whether regional BOLD signal magnitude correlated with RAVLT delayed recall performance. Four of the 6 regions which showed altered fMRI activity in e4 carriers demonstrated significant inverse correlation with the RAVLT delayed recall scores: left precuneus (r = À 0.34; P = 0.005), right ventral anterior cingulum (r = À 0.27; P = 0.03), as well as right middle (r = À 0.25; P = 0.04) and inferior (r = À 0.31; P = 0.01) prefrontal cortices (Fig. 1) . Similarly, we found the performance in the postscan recognition memory test to correlate significantly with the fMRI activity in the following brain regions: right (r = À 0.42; P<0.001) and left precuneus (r = À 0.31; P = 0.006), right ventral anterior cingulum (r = À 0.35; P = 0.002), and right inferior prefrontal cortex (r = À 0.33; P = 0.004). Altogether, greater positive BOLD signal (less deactivation) was correlated with the worse episodic memory performance.
fMRI-Effect of APOE e4 and Correlations With Memory Performance Within Healthy Elderly
We then examined the effect of e4 within the group of healthy elderly individuals (CDR 0.0). Significant differences in fMRI activity (P<0.05, cluster-corrected) between the normal e4 carriers and noncarriers were found in: right (MNI: 8, À 62, 42; Z = 3.28) and left (MNI: À 10, À 68, 44; Z = 3.09) precuneus (Fig. 2) . The ROI analysis demonstrated negative BOLD signal (preserved deactivation) in noncarriers, compared with positive BOLD signal (failure of deactivation) in the e4 carriers, similar to the paradoxical activation observed in the AD patients. Greater positive BOLD signal (less deactivation) in the left precuneus was inversely correlated with RAVLT delayed recall scores (r = À 0.39; P = 0.03) even within the healthy elderly, similar to the findings observed across all subjects. The correlation between postscan forced-choice recognition figure) . In each of these regions, magnitude of fMRI signal was greater in the e4 carriers than in noncarriers (unpaired t test, 2-tailed uncorrected P values are indicated in the figure). Difference in BOLD signal magnitude across the CDR groups was tested using 1-way analysis of variance (P values reported in the figure) . Scatter plots demonstrate the relationship between regional BOLD signal and Rey Auditory Verbal Learning (RAVLT) delayed recall scores (Pearson correlation, r and P values are indicated in the figure). The statistical map presenting significantly different activation areas in e4 carriers versus noncarriers (red-yellow) is overlaid on the statistical map demonstrating significantly different activation areas in AD patients versus healthy elderly (dark green-light green). AD indicates Alzheimer disease; BOLD, blood-oxygenlevel-dependent; CDR, Clinical Dementia Rating; fMRI, functional magnetic resonance imaging; L, left; NS, not significant; R, right. memory performance and regional fMRI activity did not reach statistical significance in the healthy older subjects only, perhaps due to the high performance on this relatively easy forced-choice recognition task in most of the healthy subjects.
DISCUSSION
This study provides evidence that the function of the posteromedial cortices is more impaired in carriers of the APOE e4 allele, compared with noncarriers, across a range of cognitive ability. Failure of memory-related deactivation in these key regions of the default network was evident even among healthy elderly individuals who carry the APOE e4 allele. Furthermore, magnitude of BOLD fMRI signal of the left posteromedial cortical region, which showed significant e4-related dysfunction, was related to verbal episodic memory performance, even within the range of cognitively normal older subjects. These findings suggest that fMRI activity in the posteromedial cortical areas of the default network is modulated by 2 major risk factors for AD, that is, the presence of APOE e4 allele and incipient episodic memory impairment.
Previous studies have reported evidence of impaired fMRI deactivation in subjects with MCI compared with the healthy elderly 3, 4 and in e4 carriers compared with the noncarriers. 27 This study investigated the entire continuum from cognitively intact subjects at genetic risk for AD to subjects with cognitive impairment (CDR 0.5) to those with clinical AD, and found that the e4 allele was associated with more impaired activity of regions of the default network throughout the course of the disease. Furthermore, e4 carriers without any clinical impairment demonstrated impaired fMRI activity in the same posteromedial cortical regions, which were found to differentiate AD patients from healthy older subjects.
Our finding of dysfunction of the posteromedial cortices in cognitively normal elderly individuals at genetic risk for AD is consistent with the previous fluorodeoxyglucose-PET results of abnormal resting-state metabolism in e4 carriers versus noncarriers 11, 12 and a recent fMRI study. 27 Furthermore, molecular PET imaging using a tracer called [
11 C]Pittsburgh Compound B, has recently provided in vivo evidence that the posteromedial cortices are among the earliest sites of amyloid b (Ab) plaque accumulation-one of the pathologic hallmarks of AD. 28, 29 Interestingly, APOE e4 is known to increase brain's vulnerability to Ab pathology, 30, 31 and even before the formation of Ab plaques, to induce neurotoxicity of soluble Ab oligomers. [32] [33] [34] Both the increased Ab plaque deposition and impaired synaptic transmission due to Ab oligomers in e4 carriers provide potential biologic mechanisms for the posteromedial cortical dysfunction observed in this fMRI study. It remains unknown that how amyloid pathology results in decreased resting glucose metabolism as observed with PET and inability to effectively modulate the neuronal activity in these posteromedial cortical regions as demonstrated with fMRI. It may be that regions which show evidence of decreased metabolism at rest are unable to respond with further decrease in activity during goaldirected task performance to support, for example, memory encoding. 35, 36 Given the strong interconnectivity between the posteromedial and medial temporal cortices, 37 it is also possible that impaired posteromedial cortical function in the e4 carriers versus noncarriers reflects remote effects of more pronounced neurofibrillary tangle pathology in the medial temporal regions of the e4 carriers. 28, 31, 38, 39 The same posteromedial regions vulnerable to hypometabolism during rest and impaired fMRI response pattern during goal-directed cognitive tasks have been proposed as key components of the default network 40 and of large-scale memory networks. 41 The cognitive operations supported by the posteromedial cortices are, however, not fully understood. In young subjects, the default network regions typically show deactivation during most goaloriented cognitive tasks, however, new fMRI studies suggest that the posteromedial cortices may have a specific role in memory formation and retrieval. There is recent fMRI evidence that deactivation of the posteromedial cortices during encoding supports successful memory formation, 35, 36 and that the same posteromedial cortices which are deactivated during successful encoding, are activated during memory retrieval. 42 Furthermore, fMRI studies suggest that retrieval-related activity of these regions is impaired in MCI. 43 Our current study is in agreement with the hypothesis that greater fMRI deactivation during encoding is related to better memory ability, even when measured via delayed recall as in standard neuropsychologic tests, both within cognitively intact older individuals and across a spectrum of clinical impairment. Interestingly, both right and left posteromedial cortical activity was significantly compromised in the e4 carriers but only magnitude of the left posteromedial fMRI signal correlated with verbal memory measures.
In this study, upregulation of the posteromedial cortical fMRI activity in subjects at risk for AD was observed in the context of a widespread network of brain areas demonstrating increased fMRI activity in e4 carriers FIGURE 2. Within the group of healthy elderly with Clinical Dementia Rating (CDR) of 0.0, fMRI activity (P<0.05, cluster-corrected) in the apolipoprotein E (APOE) e4 carriers (e4+) differed significantly from that of noncarriers (e4 À ) in the left (L) precuneus. Regionof-interest analysis revealed greater BOLD fMRI signal magnitude in the e4 carriers than in noncarriers (P = 0.001, unpaired t test). Greater positive BOLD signal (ie, reduced fMRI task-induced deactivation) was related to poorer Rey Auditory Verbal Learning (RAVLT) delayed recall performance (P = 0.03, Pearson correlation). The statistical map presenting significantly different activation areas in e4 carriers versus noncarriers (red-yellow) is overlaid on the statistical map demonstrating significantly different activation areas in Alzheimer disease (AD) patients versus healthy elderly (dark green-light green). BOLD indicates blood-oxygen-level-dependent; fMRI, functional magnetic resonance imaging. compared with noncarriers. Among these regions, similar to posteromedial cortices, the ventral anterior cingulum is often considered as part of the default network, and typically demonstrates deactivation during externally directed cognitive tasks, such as intentional encoding. 40, 41 Other regions which showed increased fMRI activity in e4 carriers, however, are parts of attentional and working memory networks, which typically activate during demanding memory tasks. Similar to our study, increased lateral prefrontal activity in e4 carriers has been reported in previous fMRI studies 44, 45 and has been interpreted to be compensatory in nature. 46 It is also possible that early AD pathology, more likely to be present in the e4 carriers, is associated with widespread cortical irritability or chronic upregulation of neuronal activity. 47 Our study has several limitations, which need to be addressed in future studies. We analyzed fMRI data from elderly subjects spanning a wide cognitive range and stratified by the APOE e4 allele status. There were, however, relatively small numbers of e4 carriers within each clinical subgroup. We did not have detailed data available on the family history of AD for all of the subjects. Recent fMRI studies have interestingly suggested complex interactions between cognitive performance, APOE genotype and family history effects on fMRI activity. 48, 49 In this study, we did not perform a whole-brain structural voxelbased morphometric analysis between the study groups, although we did use the gray matter volumes as covariates in the functional data analyses. It is worth noting that the task-related BOLD fMRI is always a relative measure investigating the net difference between 2 cognitive conditions, that is, there is not a quantitative zero baseline from which BOLD signal would vary up or down. 50, 51 It is also possible that some of the observed differences between groups were due to different cognitive strategies, that is the nature of the encoding task may have been more challenging or emotionally taxing to the subjects who have dementia or are concerned that they may have a memory problem. Patients with greater cognitive impairment may also be in a different cognitive state during the fixation baseline condition, which is also an issue in resting functional connectivity MRI studies. Nevertheless, we observed consistent alterations in posteromedial cortical activity related to both the presence of the e4 allele and performance on an episodic memory task, even among clinically normal subjects. Further clinical follow-up will be necessary to determine if these healthy older subjects will progress to demonstrate cognitive impairment and eventual clinical dementia. Finally, there may be alterations in BOLD fMRI activity that are related to neurovascular coupling or vascular factors. [52] [53] [54] Future studies may incorporate arterial spin labeling or gadolinium dynamic contrast perfusion MRI techniques to determine whether, for example, regional alterations in the baseline blood flow are responsible for some of the observed relative differences between e4 carriers and noncarriers.
In conclusion, our findings suggest that abnormal fMRI response pattern in the posteromedial cortices may be an early indicator of brain dysfunction and is related to risk factors for developing AD. Functional imaging of the posteromedial cortices may provide a sensitive technique to track alterations in neural activity due to evolving AD pathology, identify subjects at risk for developing AD, and potentially monitor response to disease-modifying therapy.
